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Drive, Jacksonville, FL 32224, United States.The regulation of apoptosis involves a complicated cascade requiring numerous protein interactions
including the pro-apoptotic executioner protein caspase-3 and the anti-apoptotic calcium-binding
protein calbindin-D28K. Using isothermal titration calorimetry, we show that calbindin-D28K binds
caspase-3 in a Ca2+-dependent fashion. Molecular docking and conformational sampling studies of
the Ca2+-loaded capase-3/calbindin-D28K interaction were performed in order to isolate potentially
crucial intermolecular contacts. Residues in the active site loops of caspase-3 and EF-hands 1 and 2
of calbindin-D28K were shown to be critical to the interaction. Based on these studies, a model is
proposed to help understand how calbindin-D28K may deactivate caspase-3 upon binding.
Structured summary of protein interactions:
Calbindin-D28K and Caspase-3 bind by isothermal titration calorimetry (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The life and death of cells must be balanced if tissue homeosta-
sis is to be maintained – there should neither be too much growth
nor too little death [1]. Normal cells accommodate this balance by
invoking apoptosis. Apoptosis is triggered via two main signaling
pathways [2]. The intrinsic pathway initiates from within the cell
by developmental cues or as a result of severe cell stress (e.g.,
DNA damage). The extrinsic pathway initiates when a pro-apoptotic
ligand binds to pro-apoptotic receptors on the cell surface. Cross-
talk between these pathways occurs at the level of the effector/
executioner caspase proteins (caspases-3, -6 and -7). Once acti-
vated, these intracellular enzymes destroy proteins that are essen-
tial for cell survival and trigger cell death. A third pathway, the
granzyme B pathway, is initiated by the constituents of cytotoxic
granules that are released upon encounter with transformed or vi-
rally infected target cells [3]. Caspases-3, -7, -8 and -10 are directly
processed by granzyme B whereas caspases-2, -6 and -9 are pro-chemical Societies. Published by E
f Molecular and Structural
olk Hall, Box 7622, Raleigh,
.
agh).
rsity of North Florida, 1 UNFcessed in a second, caspase-3-dependent, wave of processing. All
three signaling pathways route through caspase-3.
Caspase-3 targets the peptide sequence Asp-Glu-Val-Asp
(DEVD) with cleavage occurring on the C-terminal side of the sec-
ond aspartic acid residue [4,5]. The catalytic action of caspase-3 is
mediated by the sulfhydryl group of Cys 163 and the imidazole
ring of His 121 (PDB:1CP3). These are referred to as the catalytic
residues. His 121 stabilizes the carbonyl group of the key aspartate
residue, while Cys 163 attacks to cleave the peptide bond. Cys 163
and Gly 122 also stabilize the tetrahedral transition state of the
substrate–enzyme complex [5]. If caspase-3 function is impeded
then apoptosis is hindered. Not surprisingly, therapeutics are being
developed to affect various caspase family members. With few
exceptions, all of the proof-of-concept preclinical studies with cas-
pase inhibitors have been performed with active-site mimetic pep-
tide ketones. From a drug development standpoint, the most
attention has been paid to caspase-3 [6]. However, to this point
no therapeutics have reached the clinic, making alternate ap-
proaches for inhibiting caspase-3 action appealing.
The Ca2+-binding EF-hand protein calbindin-D28K is known to
interact with caspase-3 and inhibit apoptosis. Its anti-apoptotic
properties have been demonstrated in neuronal cells, osteocytes,
osteoblasts, and lymphocytes [7–9]. It is suggested that calbin-
din-D28K is not a substrate for caspase-3 itself (i.e., does not occu-
py the caspase-3 binding site) as it is not cleaved signiﬁcantly by
the enzyme [9]. When apoptosis is initiated, Ca2+ concentrationslsevier B.V. All rights reserved.
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Calbindin-D28K also inhibits degradation of synthetic and natural
caspase-3 substrates while other Ca2+-binding proteins do not. This
indicates that its ability to limit apoptosis is not simply due to
Ca2+-buffering properties, but also because it directly interacts
with caspase-3. The caspase-3/calbindin-D28K interaction has
been shown to be speciﬁc since other Ca2+-binding proteins (cal-
modulin, S100, calbindin-D9k and osteocalcin) do not inhibit cas-
pase-3. Binding between calbindin-D28K and caspase-3 has been
suggested to be independent of Ca2+, i.e., the binding event is the
same regardless of whether calbindin-D28K is in its apo-state or
in one of its partially/fully Ca2+-loaded forms [9].
Our previous studies indicate a notable difference between the
structures of apo-calbindin-D28K and its fully-loaded (4Ca2+) form
[10]. It would be surprising if these two forms of calbindin-D28K
bound to caspase-3 identically. Consequently, we wanted to fur-
ther examine any Ca2+-dependency of the caspase-3/calbindin-
D28K interaction. To do this we used a combination of circular
dichroism, NMR and isothermal titration calorimetry. Our studies
reveal that the caspase-3/calbindin-D28K interaction is, in fact,
dependent upon calbindin-D28K’s level of Ca2+-loading. Addition-
ally, we performed computational docking studies and conforma-
tional sampling simulations, using the structures of fully Ca2+-
loaded calbindin-D28K (NMR) and caspase-3 (X-ray). These studies
furnish the ﬁrst model for the complex and suggest a possible
mechanism by which calbindin-D28K contributes to the deactiva-
tion of caspase-3 and inhibits apoptosis.
2. Materials and methods
2.1. Sample preparation
The expression and puriﬁcation of calbindin-D28K have been
described [10–12]. Apo-calbindin-D28K solutions were prepared
with 5 mm EDTA in all puriﬁcation steps. The expression and puri-
ﬁcation of caspase-3 is as previously described [13].
2.2. Circular dichroism
All CD measurements were obtained on an Applied Photophys-
ics Chirascan Plus CD Spectrometer with calbindin-D28K samples
at 5 lM for far UV (260–190 nm) measurements at 25 C. The sam-
ples were equilibrated overnight in 10 mM Tris buffer (pH 6.5),
with appropriate CaCl2 concentrations to obtain 1:1, 1:2, 1:3, and
1:4 calbindin-D28K/Ca2+ molar ratios. Apo-calbindin-D28K sam-
ples were equilibrated overnight in 10 mM Tris (pH 6.5), 5 mM
EDTA.
2.3. Isothermal titration calorimetry
For ITC measurements, puriﬁed calbindin-D28K and caspase-3
were buffer exchanged into 50 mM HEPES (pH 7.5), 100 mM NaCl,
1 mM b-mercaptoethanol (bME) and 10% glycerol. For the apo-
samples, 1 mM EDTA was added. For the fully and partially Ca2+-
loaded states of calbindin-D28K, equivalent molar ratios of CaCl2
were added from 1 to 6 (to ensure complete loading). The experi-
ments were performed at 26 C using an AutoITC200 microcalo-
rimeter (GE MicroCal Inc.). The apo- and partially Ca2+-loaded
experiments were performed by injecting 2 ll of 800 lM calbin-
din-D28K into a 200 ll sample cell containing 50 lM caspase-3.
The fully Ca2+-loaded experiments were performed by injecting
2 ll of 500 lM calbindin-D28K into a 200 ll sample cell containing
30 lM caspase-3. A total of 20 injections were performed with a
spacing of 180 s and a reference power of 7 lcal/s. Control
experiments for each buffer (apo- and Ca2+-loaded states) were
also performed, and heat of dilution was measured by titratingcalbindin-D28K into buffer alone. The heat of dilution generated
by calbindin-D28K was subtracted, and the binding isotherms
were ﬁt to a one-site and two-site binding model using Origin 7
Software (MicroCal, Inc.). The data analysis protocol and appropri-
ate equations for analyzing the caspase-3/calbindin-D28K interac-
tion by ITC are provided in Supplementary data.
2.4. ‘Blind’ molecular docking
High ambiguity driven protein–protein docking (HADDOCK)
was set up as follows: coordinate ﬁles for Ca2+-loaded calbindin-
D28K and caspase-3 were obtained from the PDB (2G9B and
1CP3, respectively) [12,14,15]. All residues with solvent accessibil-
ity of 50% or greater were deﬁned as ‘active’. No residues in either
protein were deﬁned as being ‘passive’. The caspase-3 PDB was
modiﬁed to include only one monomer of caspase-3 and the
dimerization interface of caspase-3 was excluded as a region for
interaction between calbindin-D28K and caspase-3. Default HAD-
DOCK parameters were used. Final structures were grouped using
a minimum cluster-size of 4 with a Ca RMSD <7.5 Å using ProFit
(http://www.bioinf.org.uk/software/proﬁt/) and further grouped
based on the ‘‘HADDOCK SCORE’’.
2.5. ‘Targeted’ molecular docking
The ‘targeted’ molecular docking was performed similarly, with
the following exceptions: (1) active residues (3, 9, 22, 25–27, 34,
41, 45, 48–51, 53, 56, 59–60, 63–64, 67, 69–70, 83, 86–87) for cal-
bindin-D28k were deﬁned as residues within EF-hands 1 and 2
with greater than 50% solvent accessibility; (2) passive residues
(97–98, 105, 109, 112- 113, 121, 128, 132, 135, 137, 140–141,
157–159, 174–175, 183, 185, 189, 192–193, 196–197, 200–201,
204, 209, 220–221, 224, 228–229, 236, 244, 250, 261) for calbin-
din-D28K were deﬁned as residues not within EF-hands 1 and 2
with greater than 50% solvent accessibility; (3) active residues
(53–54, 56–58, 60, 62–63, 68, 209–210, 246, 248, 250, 252–255)
for caspase-3 were deﬁned as residues with greater than 50% sol-
vent accessibility on the active site surface (including the loop-
bundles); and (4) passive residues (35, 38, 42, 72, 80, 82, 89, 94,
102, 105, 107, 110, 123–124, 135, 137, 138, 147, 149, 153, 166–
167, 170, 173, 185, 224–225, 228–229, 277) for caspase-3 were de-
ﬁned as residues not within the active site surface with greater
than 50% solvent accessibility.
2.6. Reﬁnement of the docked solutions
The lowest energy structure from the ‘targeted’ molecular dock-
ing within the highest populated cluster of structures was reﬁned
with 2000 ps of implicit solvent reﬁnement implemented in AM-
BER 11 [16] to account for solvent effects and eliminate structural
imperfections as deﬁned via WHATCHECK [17]. The structure was
further analyzed by PROCHECK [18] to conﬁrm stereochemical
quality and also to check for clashes in the interface region by tleap
in AMBER; no signiﬁcant clashes were detected.
2.7. Conformational sampling simulation
Conformational transitions simulations were performed on the
caspase-3 structure using tCONCOORD [19]. Standard tCONCOORD
parameters were used; maximum distance for hydrogen bonds
was set to 2.6 Å with a minimum angle for hydrogen bonds of
140 [19]. Hydrophobic backbone–backbone, sidechain–backbone
and sidechain–sidechain protections were used throughout the
simulation. Bond ﬂexibility was set to 0.04 Å, angle ﬂexibility
was set to 0.1 Å and 9.0, planarity tolerance was set to 0.03, ﬂex-
ibility for restricted dihedrals was set to 0.1%, and ﬂexibility for
3584 B.G. Bobay et al. / FEBS Letters 586 (2012) 3582–3589non-restricted dihedrals was set to 0.6%. The same tCONCOORD
procedure was used for all PDBs.
3. Results
3.1. Circular dichroism
Previous NMR studies showed that calbindin-D28K transitions
from an ordered, structured conformation in its apo-state throughFig. 1. ITC raw data and binding curve for the interaction between calbindin-D28K a
interaction between 1:1 calbindin-D28K/Ca2+ and caspase-3. (C) ITC interaction between
D28K/Ca2+ and caspase-3. (E) ITC interaction between fully Ca2+-loaded calbindin-D28Ka set of more disordered states when loaded with successive
amounts of Ca2+ [10]. When it is ﬁnally fully Ca2+-loaded (4Ca2+),
it adopts a different ordered, structured conformation. These CD
data were obtained for apo-calbindin-D28K and calbindin-D28K
loaded with 1Ca2+, 2Ca2+, 3Ca2+ and 4Ca2+. All spectra display min-
ima at 208 and 222 nm, which is characteristic of alpha-helical
proteins. Supplementary Fig. 1 shows an overlay of CD data from
each calbindin-D28K Ca2+-loaded state. Interestingly, the extent
of helical content appears constant in all states. Accordingly, wend caspase-3. (A) Interaction between apo calbindin-D28K and caspase-3. (B) ITC
1:2 calbindin-D28K/Ca2+ and caspase-3. (D) ITC interaction between 1:3 calbindin-
and caspase-3.
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bound to caspase-3 using ITC. All samples were checked for struc-
tural quality prior to ITC analysis by CD and NMR.
3.2. Isothermal titration calorimetry
ITC binding experiments (Fig. 1) indicate the following: (i) apo-
calbindin-D28K does not bind caspase-3; (ii) 1Ca2+-loaded calbin-
din-D28K binds to caspase-3 with the binding most closely
approximating a two-site model with an N-value (reaction stoichi-
ometry) of 0.64 and 1.32; (iii) 2Ca2+-loaded calbindin-D28K binds
to caspase-3 with the binding most closely approximating a two-
site model (N-values of 1.28 and 1.90); (iv) 3Ca2+-loaded calbin-
din-D28K binds to caspase-3 with the binding moving from a
two-site model more towards a one-site model (N-values of 1.60
and 0.53); (v) fully Ca2+-loaded calbindin-D28K binds to caspase-
3 with the binding most closely approximating a one-site model
(N-value of 1.05). In each case the binding occurs with low micro-
molar afﬁnity. These data are summarized in Table 1.
3.3. Computational docking
Initially, ‘blind’molecular docking of calbindin-D28K to caspase-
3 was performed. Here, the only contact restraint invoked was that
interacting residues should have a minimum of 50% solvent acces-
sibility. The ‘blind’ molecular modeling resulted in 13 clusters
shown in Supplementary Fig. 2. These structural clusters suggestedTable 1
Isothermal titration calorimetry data for the interaction between caspase-3 and calbindin
Calbindin/Ca2+ molar ratio Kd 1, lM (error) Kd 2, lM (erro





aStandard deviations shown in parentheses. Stoichiometry is included for each sample a
Fig. 2. Lowest energy AMBER reﬁned complex. (A) The lowest energy AMBER reﬁned c
calbindin-D28K is colored with regard to its EF-hand pairs: EF-hand 1 (red), EF-hand 2
(purple). All other a-helical domains connecting the EF-hands are colored white. (B) W
Caspase-3 catalytic residues are shown as spheres with hydrogens removed. Loops andthat the main location for the interaction occurs at the active site
loops of caspase-3 with EF-hands 1 and 2 of calbindin-D28K. The
‘active site loops’ consist of loops 1, 3 and 4 from one monomeric
unit of the caspase-3 dimer and loop 2’ from the other monomeric
unit [20]. In each case, calbindin-D28K does not directly interact
with the catalytic residues His 121 and Cys 163 of caspase-3. We
deﬁne ‘not directly interacting’ as a distance (Ca–Ca) of at least
4.5 Å between residues in calbindin-D28K and the catalytic resi-
dues in caspase-3. Lending support to these preliminary studies
was that the binding region identiﬁed on calbindin-D28K is similar
to a region on calbindin-D28K shown previously to be involved in
interactions with peptides derived from known targets [11].
The results of the blind docking laid the groundwork for a more
directed approach that involved targeting solvent accessible resi-
dues within EF-hands 1 and 2 of calbindin-D28K with the active
site loops of caspase-3. This resulted in 3 total clusters with clus-
ter-1 containing 70% of the docked solutions. Here, a cluster-is
deﬁned as a minimum of 20 structures (10% of the total structures
solved) and a maximum RMSD of 7.5 Å over all structures (Supple-
mentary Fig. 3). The lowest energy structure within the greatest
populated cluster-was further reﬁned in AMBER (Fig. 2). Fig. 2A
shows the caspase-3 dimer binding symmetrically to two calbin-
din-D28K molecules. Fig. 2B shows the interaction more clearly,
with only one caspase-3 monomer and one calbindin-D28K de-
picted. Since cluster-1 is by far the most populated, we focus our
mechanistic discussions on this model, though other lesser popu-
lated clusters may have some relevance.-D28K.





s N1 and N2.
omplex between calbindin-D28K and caspase-3. Caspase-3 is colored beige while
(orange), EF-hand 3 (yellow), EF-hand 4 (green), EF-hand 5 (blue) and EF-hand 6
ild-type caspase-3/calbindin-D28K complex. Coloring is the same as in panel (A).
EF-hands are labeled for clarity.
Fig. 3. Hydrogen bond and salt bridge interactions. Coloring is identical to Fig. 2. (A) Hydrogen bonds (orange lines) between calbindin-D28K and caspase-3’s loop 1. (B)
Hydrogen bonds (green lines) between calbindin-D28K and caspase-3’s loop 3. (C) Hydrogen bonds (yellow lines) between calbindin-D28K and caspase-3’s loop 4. (D) Salt
bridge (magenta line) between calbindin-D28K and caspase-3’s loop 1. Caspase-3 catalytic residues are shown as spheres with hydrogens removed.
3586 B.G. Bobay et al. / FEBS Letters 586 (2012) 3582–3589As discussed below, the main interaction region consists of EF-
hands 1 and 2 from calbindin-D28K with the active site loops of
caspase-3, particularly loop 1 – though all loops contribute to some
degree. This region is dominated by protein/protein interactions
between residues 21–27 of calbindin-D28K (end of a-helix 1 of
EF-hand 1) and residues 57–65 of caspase-3 (loop 1). The helical
domain of EF-hand 1 (a-helix 2–residues 33–50) governs the inter-
action by intercalating itself between loops 1 and 2 with interac-
tions to caspase-3 residues 59–62 (loop 1), 166 (loop 2), 206–211
(loop 3) and 250–256 (loop 4). The helical domain of EF-hand 2
(a-helix 1–residues 56–67) primarily interacts with caspase-3 res-
idues 251–255 (loop 4). Also, potentially stabilizing the interaction
between calbindin-D28K and caspase-3 are a network of hydrogen
bonds. These interactions are predominantly located between EF-
hand 1 (a-helices 1 and 2) of calbindin-D28K and loop 1 of cas-
pase-3 (Fig. 3A – orange lines). Additionally several more hydrogen
bonds are suggested to be present between: (a) EF-hand 1 (a-helix
2) of calbindin-D28K and loop 3 of caspase-3 (Fig. 3B – green lines),
(b) EF-hand 1 (a-helix 2) and EF-hand 2 (a-helix 1) of calbindin-
D28K and loop 4 of caspase-3 (Fig. 3C – yellow lines). Finally, there
is an important salt bridge between Asp 24 of calbindin-D28K and
Lys 57 of caspase-3 (Fig. 3D – magenta line).
When comparing the structures of caspase-3 in its unbound
form (X-ray) and its bound form (docked model) it is evident that
loops 1 and 4 show the biggest change in position (see Section 4).3.4. Conformational sampling
Since loops 1 and 4 of caspase-3 showed the largest conforma-
tional adjustment on calbindin-D28K binding, we performed con-
formational sampling simulations on these loops to investigate
any potential motional changes due to the interaction. As dis-
cussed below, in the case of both loops there is a notable reduction
in the conformational space being sampled upon calbindin-D28K
binding. Comparing loop RMSD’s between uncomplexed and com-
plexed states there is a 22% decrease for loop 1 and a 15% decrease
for loop 4. These data suggest that the conformational shifts of cas-
pase-3 loops 1 and 4 upon binding calbindin-D28K are accompa-
nied by a reduction in ﬂexibility in both cases, trapping them in
their new positions to some degree (see Section 4).4. Discussion
In this work we studied the interaction between the pro-apopto-
tic protein caspase-3 and its natural inhibitor, the anti-apoptotic
protein calbindin-D28K. Calbindin-D28K is one of many Ca2+-bind-
ing proteins within a cell, but the only one that is seen to directly
bind caspase-3 [9]. The implications of this interaction are of signif-
icant interest in the areas of general apoptosis [21,22], cancer
[21,23], neurodegenerative disease [22,24,25] and diabetes [26–28].
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dergo a conformational change between its apo- and fully Ca2+-
loaded states, while CD studies show it maintains the same level
of a-helical content. This suggests that the helices shift conforma-
tion but neither extend/unravel as more Ca2+ binds. Subsequent
ITC studies showed that apo-calbindin-D28K does not bind cas-
pase-3. This implies that apo-calbindin-D28K does not contain
the minimum structural motif required for caspase-3 recognition.
The addition of a single Ca2+ to calbindin-D28K appears to provide
enough of a structural change that this minimum recognition motif
appears, since 1Ca2+-loaded calbindin-D28K binds to caspase-3.
This interaction occurs predominantly according to a two-site
binding model. As calbindin-D28K becomes more Ca2+-loaded we
observe that the protein continues to interact with caspase-3,
though the interaction moves towards a one-site binding model.
When calbindin-D28K becomes fully Ca2+-loaded it interacts with
caspase-3 primarily in a one-site binding mode. The evolution of
a ‘two-state-to-one-state’ binding model lends weight to previous
NMR and mass spectrometric studies on calbindin-D28K which
suggest that the protein passes from an ordered apo-state through
ﬂexible states at intermediate levels of Ca2+-binding, to a different
ordered state when fully Ca2+-loaded [10]. In the intermediate
Ca2+-loaded states the protein appears to possess sufﬁcient ﬂexibil-
ity to contact caspase-3 in a two-site fashion. This means that
D28K contacts caspase-3 in two independent, non-symmetric loca-
tions. It is likely that these two contact regions are located quite
close to one another.
As the protein becomes more ordered when fully Ca2+-loaded,
the concomitant loss of ﬂexibility assures a single binding mode.
Most importantly, these studies demonstrate that the interaction
between calbindin-D28K and caspase-3 is dependent on the level
of Ca2+ bound to calbindin-D28K. NMR NH-HSQC spectra of apo-
calbindin-D28K and fully Ca2+-loaded calbindin-D28K are shown
in Supplementary Fig. 4 to illustrate this conformational change.
Molecular modeling/docking studies were carried out in order
to provide the ﬁrst detailed insights into the calbindin-D28K/cas-
pase-3 interaction and to suggest a mechanism by which calbin-
din-D28K may inhibit caspase-3 function. Caspase-3 displaysFig. 4. Known caspase-3/protein (non-peptide) interactions. (A) Crystal structure of th
complex between DARPIN-3.4 and caspase-3. (C) Lowest energy AMBER reﬁned comp
residues are shown as spheres with hydrogens removed except panel (A). Calbindin-D2tremendous preference for the peptide sequence DEVD, enabling
a 20,000-fold preference for aspartic acid over glutamic acid [4].
Such selectivity is due to very speciﬁc active site characteristics,
which are in large part driven by the active site loops. Within these
loops there are several stabilizing hydrogen bond and charge-
charge interactions that are necessary to correctly align the active
site. If anything perturbs this precise arrangement, then cleavage
cannot occur and caspase-3 function is impeded.
Our studies predicted three possible binding models for the cal-
bindin-D28K/caspase-3 interaction, with one of the binding modes
containing 70% of the solved structures (cluster-1) (Supplementary
Fig. 3A). In the cluster-1 model, calbindin-D28K’s primary areas of
contact with caspase-3 reside in EF-hands 1 and 2, with residues
33–50 (GKELQNLIQELLQARKK) occupying the cleft between loops
1 and 4 of caspase-3. No residues from calbindin-D28K were pre-
dicted to directly interfere with caspase-3’s catalytic residues.
However, calbindin-D28K does take up position such that access
to the catalytic cleft is hampered. Certainly this would affect the
ability of caspase-3 to perform its enzymatic function.
This model is consistent with the structures solved for other
complexes between caspase-3 and: (i) XIAP_BIR2 (PDB:1I30)
and (ii) DARPIN-3.4 (PDB:2XZD) (Fig. 4A and B, respectively).
Although, slightly different, in both these cases XIAP_BIR2 and
DARPIN-3.4 are positioned such that the caspase-3 active site is
occluded. The two interactions are different however. In the cas-
pase-3/XIAP_BIR2 complex, direct contacts between XIAP_BIR2
and the caspase-3 catalytic site are seen (contacts 3 Å). As a
note, in the caspase-3/XIAP_BIR2 complex, the caspase-3 catalytic
residue Cys 163 was mutated to alanine. Conversely, the casapse-
3/DARPIN-3.4 complex shows that no DARPIN residues are closer
than 5 Å to the caspase-3 catalytic residues. This latter binding
event is more similar to the caspase-3/calbindin-D28K complex
modeled here (Fig. 4C). For the modeled caspase-3/calbindin-
D28K complex (cluster-1) there are also no direct contacts seen
between calbindin-D28K and the catalytic residues in caspase-3.
The calbindin-D28K residue Asn 38 is the closest residue to
the caspase-3 catalytic residues His 121 and Cys 163, at 6 Å
(Ca–Ca).e complex between XIAP_BIR2 and C163A caspase-3. (B) Crystal structure of the
lex between calbindin-D28K and caspase-3. Caspase-3 is colored beige; catalytic
8K has identical coloring schemes as in Fig. 2.
Fig. 5. Alternate loop conformations of caspase-3. The lowest energy AMBER reﬁned complex between calbindin-D28K and caspase-3 overlaid with caspase-3 prior to
docking. Docked caspase-3 is colored in beige while calbindin-D28K is colored identical to Fig. 2. Caspase-3 prior to docking (PDB:1CP3) is colored light blue. The image is
rotated 90 degrees to clearly show the conformational changes that the labeled loops undergo upon binding calbindin-D28K. Caspase-3 catalytic residues are shown as
spheres with hydrogens removed.
Fig. 6. Conformational sampling of caspase-3 loops 1 and 4. (A) Unbound caspase-3
(blue) with the calculated conformational space being sampled by loop 1 (red) and
loop 4 (yellow). (B) Caspase-3 (green) when bound to calbindin-D28K with the
calculated conformational space being sampled by loop 1 (red) and loop 4 (yellow).
Note the reduction in sampled space by both loops in (B).
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restricts substrate entry to caspase-3’s catalytic cleft, our modeling
studies suggest another potential contribution to caspase-3 inhibi-
tion. Previously the active site loops in caspase-3 have been shown
to be critical to its activation, possibly through dynamic motions as
seen in molecular dynamic simulations [20,29]. In the molecular
modeling performed here, caspase-3 principally uses the active site
loops to interact with several regions of calbindin-D28K, primarily
EF-hands 1 and 2 (Figs. 4 and 5) [20]. Comparing the positions of
the loops in caspase-3 before and after the docking (cluster-1), it
is seen that loops 2 and 3 undergo only slight conformational rear-
rangement. However, signiﬁcant conformational changes are seen
for both loops 1 and 4 (Fig. 5). In the docked model of the cas-
pase-3/calbindin-D28K complex the presence of the calbindin-
D28K alters the position of loop 1 from caspase-3 such that it oc-
cludes the catalytic site. The functional ability of caspase-3 may
well be impeded due to this limited access for substrates. Concom-
itantly, the hydrogen bonding networks of both loops are altered,
likely affecting critical conformational requirements for function
(see Supplementary Table 1).
Subsequent conformational sampling simulations were per-
formed, with emphasis on loops 1 and 4 of caspase-3 in both its
unbound state and when in complex with calbindin-D28K
(Fig. 6). Comparing loops 1 and 4 before and after calbindin-
D28K binding shows that both exhibit reduced motional tendency
in the bound state. The largest difference is for loop 1 where the
reduction in conformational space being sampled is 22%. For loop
4 the reduction in conformational space being sampled is 15%.
Not only does it appear that the position of loops 1 and 4 change
upon calbindin-D28K binding, but also that both loops become
more conformationally trapped. These reduced motions may also
contribute to calbindin-D28K’s ability to affect caspase-3 function.
Here we have demonstrated that the interaction between the
anti-apoptotic protein calbindin-D28K and its target, the pro-apop-
totic executioner protein caspase-3, is dependent on the amount of
Ca2+ bound to calbindin-D28K. We also note that as the protein
transitions from its ordered apo-structure to its ordered (but dif-
ferent structured) fully Ca2+-loaded form, its helical contentremains constant. Molecular modeling/docking studies using the
high-resolution structures of caspase-3 and calbindin-D28K sug-
gest that calbindin-D28K does not directly interact with the cas-
pase-3 catalytic residues, supporting previous biochemical
studies [9]. We propose a model of calbindin-D28K occupying a po-
sition that blocks the catalytic site on caspase-3. The concomitant
shifting and reduction in motion of loop 1 (especially) and loop 4 in
casapse-3 upon binding may also obstruct substrate access to the
catalytic site and disrupt the optimum bonding network within
the active site loops. These changes may adversely affect the apop-
totic function of caspase-3. As far as we are aware this is the ﬁrst
model to describe a possible mechanism of action for the ability
of calbindin-D28K to deactivate caspase-3. Finally, it is worth not-
ing that in mature caspase-8, the position of loop 1 is such that the
active site is available and ensures that catalytic activity can pro-
ceed. However, the NMR structure of inactive procaspase-8 shows
that loop 1 adopts a position that occludes the active site [30]. This
is a similar situation to that described here, supporting our model.
B.G. Bobay et al. / FEBS Letters 586 (2012) 3582–3589 3589Here, loop 1 from caspase-3 is removed from the active site allow-
ing proteolytic cleavage to occur unhindered. Loop 1 can be moved
to obstruct the active site by the interaction with calbindin-D28K.
It will be interesting to see if this proposed mechanism becomes a
more general theme contributing to caspase inhibition.
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